Worldwide Diarrhea Insulin, Why Do It Down
Diabetes is considered to be the product of a poor lifestyle of cities:
In the case of type-2 diabetes, insulin is not sufficient in order to control the amount of sugar in the victim’s blood. Scientists believe that for millions of people suffering from type 2 diabetes, it can be difficult to get insulin for a decade or more. At present, around 40 million people from 20 to 79 years of age are suffering from type-2 diabetes. More than half of these people live in China, India and the United States. By 2030, the number of people suffering from type-2 diabetes is expected to reach 50 million. Apart from this, type-1 diabetes is also there. In this, the victim’s body starts to harm the penicillin producing insulin.
Lack of insulin in the world:
According to a study published in the Lancet Diabetes and Endocrinology Journal, about 8 million people suffering from type-2 diabetes by the year 2030 will need insulin. By 2030, the demand for this drug is expected to increase by 20 percent. But more than half of these people (probably in Asia and Africa) will not be able to get this medicine. At present, about 3.3 million people are in need of insulin and they are unable to achieve this medication.
The lack of insulin means:
Dr. Sanjay Basu, head of the team studying the availability of insulin, explains the equation of the availability, demand, and supply of this drug, saying, “Access to this drug of diabetics means that insulin is available to the people and People are also financially capable of buying it. ” “There should be a supply chain along with the price so that this drug kept in the fridge and the needles provided along with it can be safely distributed.”
Why insulin is so expensive?
Insulin is 97 years old medicine, which was called ‘miraculous medicine’ in the 20th century. Why is this medicine so expensive after so many years? This is a big question. According to scientists, 99 percent of the global insulin market of Rs 1554 billion is owned by three multinational companies – Novo Nordic, Illy Lily, and Company and Sanofi. Along with that, these companies have a 96 percent stake in the size of the market. These three companies supply insulin to the entire United States.
More than 91 countries in 132 countries around the world do not charge any kind of insulin. But despite this, this drug is very expensive for the people because due to the expenses incurred on the supply chain as well as taxes, the drug is out of reach of people. About 20 million people in the United States suffer from diabetes. Between 2000 and 2010, the incidence of diabetes sufferers’ insulin increased to 89 percent. This applies even to the adult people living in the circumference of the insurance. The price of insulin per woman has increased from Rs. 2960 to about Rs. 9620. A vial just moves for a few days. There are many questions about the availability of this drug. According to Dr. David Henry Barron associated with the Geneva University Hospital and Geneva University, “Countries have very few options in terms of suppliers, so people have to be forced to change the type of insulin because companies provide some formulations. has stopped.”
At present, there are five types of insulin medicines available in the world. In this way, doctors prescribe medicines that give them the most benefits in terms of their lifestyle, age, blood sugar goals, and daily injections. But if the availability of medicines is concerned, the supply of insulin is a problem for those countries where the average income is low or middle level. Studies on the availability of insulin have shown that availability of insulin has been found in Bangladesh, Brazil, Malawi, Nepal, Pakistan, and Sri Lanka. Along with this, poor management and ineffective distribution can cause problems in supply. For example, 77 percent of insulin supply in Mozambique is possible only in the capital. Because of this, the lack of insulin is seen throughout the country. Dr. Barron says, “There is no availability of insulin in the world and the ability to buy out is a threat to life and it challenges the right to health.”
Generic drug of insulin:
The question is, why is the drug that was discovered almost a hundred years ago still not available as a generic medicine for the people. Scientists who invented insulin sold their drug patents to the University of Toronto for a dollar. After the expiry of the period of the patent of any drug, it usually becomes quite cheap. For this, companies that make generic drugs should be called thank you. But this did not happen in this drug case. Scientists Jeremy A. Green and Kevin Riggs say that one of the reasons may be that insulin is made from living cells and its formula is more complex than copying. Simultaneously, the companies making generic medicines have not yet considered this drug as worthless to try to make its generic drug. Similar biological insulin is also available in the market and available at relatively cheap prices. But they are not as cheap as generic drugs. Scientists say insulin should be included in the Universal Health coverage packages. At the same time, there is a need to spend money to explore the distribution and maintenance of diabetes. It clearly shows that factors like weak medical systems, expensive insulin delivery systems, and prices influence the reach of people of insulin. Dr. Basu says, “Work needs to be done with cost and distribution process. Unless these issues work, people are not able to recover from the lack of insulin.”
I am a market research professional, currently working in the Industrial and Consumer Goods domain. I have worked on several critical projects of Consumer Goods, Industrial, and ICT in coordination with Fortune 500 companies,
I have completed my Masters in Economics from Calcutta University, Bachelor in Economics from Bethune College. In addition to this, I have completed Data Analytics Course from Ivy Professional School and I am proficient in tools like SAS, R, STATA, and also proficient in Advanced Excel, SQL, VBA.